[28P2-am1-156] Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.